Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Azuwana Supian"'
Autor:
Asrul Akmal Shafie, Azuwana Supian, Mohamed Azmi Ahmad Hassali, Lock-Hock Ngu, Meow-Keong Thong, Hatijah Ayob, Nathorn Chaiyakunapruk
Publikováno v:
PLoS ONE, Vol 17, Iss 8, p e0273939 (2022)
[This corrects the article DOI: 10.1371/journal.pone.0230850.].
Externí odkaz:
https://doaj.org/article/6768e1cda2f646c59bacc10829d20c86
Autor:
Asrul Akmal Shafie, Azuwana Supian, Mohamed Azmi Ahmad Hassali, Lock-Hock Ngu, Meow-Keong Thong, Hatijah Ayob, Nathorn Chaiyakunapruk
Publikováno v:
PLoS ONE, Vol 15, Iss 4, p e0230850 (2020)
ObjectiveRare diseases are often underdiagnosed, and their management is frequently complicated by a lack of access to treatment and information about the diseases. To allow for better policy planning, we sought to examine the current status of manag
Externí odkaz:
https://doaj.org/article/d9f27a74728f490a888f7f16e712d210
Autor:
Azuwana Supian, Asrul Akmal Shafie
Generally, most of rare disease patients receive little attention. Although affecting only few hundreds of Malaysian, yet looking at rare diseases as a collective their impact is expensive. Unfortunately, there is no specific act, system or even guid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::79ec37eca2504105ea91b38873ad0c68
https://doi.org/10.17504/protocols.io.6zdhf26
https://doi.org/10.17504/protocols.io.6zdhf26
Autor:
Asrul Akmal Shafie, Hatijah Ayob, Mohamed Azmi Hassali, Lock-Hock Ngu, Nathorn Chaiyakunapruk, Azuwana Supian, Meow-Keong Thong
Publikováno v:
PLoS ONE, Vol 15, Iss 4, p e0230850 (2020)
PLoS ONE
PLoS ONE
ObjectiveRare diseases are often underdiagnosed, and their management is frequently complicated by a lack of access to treatment and information about the diseases. To allow for better policy planning, we sought to examine the current status of manag
Autor:
Rickard E. Malmström, Hanne Bak Pedersen, Marija Kalaba, Anna Bucsics, Kristina Garuoliene, Laura McCullagh, Ali Alkan, Vera Vlahović-Palčevski, Elif Hilal Vural, Azuwana Supian, Kaisa Miikkulainen, Stephen Campbell, Einar Magnisson, Eduardo Diogene, Sisira Jayathissa, Faridah Yusof, Alexander E. Finlayson, Augusto Afonso Guerra Junior, Susan Spillane, Wenjie Zeng, Irene Eriksson, Low Ee Vien, Gabriela Ofierska-Sujkowska, Winnie de Bruyn, Angela Timoney, Anna Brzezinska, Lars L. Gustafsson, Janet Wale, Catherine Sermet, Gisbert Selke, Jurij Fürst, Saira Jan, Jadwiga Czeczot, Andy Gray, Roberta Joppi, Francisco de Assis Acurcio, Jolanta Gulbinovič, Brian Godman, Magdalene Wladysiuk, Ilse Truter
Publikováno v:
Expert review of clinical pharmacology. 8(1)
Medicines have made an appreciable contribution to improving health. However, even high-income countries are struggling to fund new premium- priced medicines. This will grow necessitating the development of new models to optimize their use. The objec
Autor:
Nathorn Chaiyakunapruk, Mohamed Azmi Hassali, Asrul Akmal Shafie, Jeremy Lim, Matt Zafra, Azuwana Supian
Publikováno v:
Orphanet Journal of Rare Diseases
Background Rare diseases, also referred to as orphan diseases, are characterised by their low prevalence with majority of them are chronically debilitating and life threatening. Given the low prevalence and the widely dispersed but very small patient